Bayer Will Appeal India Compulsory Licence On Its Cancer Drug 05/03/2013 by Intellectual Property Watch 7 Comments German pharmaceutical manufacturer Bayer has announced it will appeal yesterday’s ruling in India that upheld a compulsory licence on one of its drugs.
India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue 04/03/2013 by Patralekha Chatterjee for Intellectual Property Watch 6 Comments New Delhi – India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG’s kidney and liver cancer drug Nexavar in the market.
Should Industry Support LDCs’ Request For Unlimited Time To Implement The TRIPS Agreement? Absolutely 04/03/2013 by Intellectual Property Watch 3 Comments Nick Ashton-Hart writes: Some of you may have noticed that the ICT sector trade association that I represent in Geneva, the Computer and Communication Industry Association (CCIA), has endorsed a bid by the world’s Least Developed Countries (LDC’s) to remove any specific deadline for full compliance with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.
Patent Pool-ViiV Collaboration On Paediatric HIV Sparks Reactions, Hope 04/03/2013 by William New, Intellectual Property Watch 1 Comment The Medicines Patent Pool has announced a ground-breaking collaboration with a private sector joint venture that it said will facilitate greater availability of critical medicines for children with HIV worldwide. The announcement caused a wave of positive reactions across the public health community, with many hoping for more in the future.
Global Fund Launches New Funding Model 01/03/2013 by Intellectual Property Watch Leave a Comment The Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, has announced a new funding model that aims to allow for more strategic investment.
WIPO Patent Law Committee Cinches Agreement On Future Work 01/03/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment With the threat of suspension of work looming, the World Intellectual Property Organization Standing Committee of the Law of Patents (SCP) agreed to a minimal programme of work, which includes exceptions and limitations to patent rights, quality of patents, and patents and health. Delegates made significant concessions on all sides, but the Africa Group expressed particular disappointment in the limited commitment to work on the patents and health topic.
Russia Establishes Specialised Court For Intellectual Property Rights 01/03/2013 by Daria Kim for Intellectual Property Watch 1 Comment As of 1 February 2013, a specialised court for intellectual property rights (the IPR Court) is instituted within the system of commercial (‘arbitrazh’) courts of the Russian Federation.
Speakers Outline Ideas For Africa To Find Appropriate IP Policies 01/03/2013 by Linda Daniels for Intellectual Property Watch 6 Comments Johannesburg, South Africa – Africa is still held captive by colonial borders and has failed to collectively leverage benefit-sharing agreements that result from multinationals’commercial pursuit of indigenous knowledge, said speakers at the Africa IP conference this week.